Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This phase 2 multicenter clinical trial assess the safety and efficacy of inhaled PPP001 to
relieve the pain in 78 advanced cancer patients with uncontrolled symptoms. This is a 4-week
treatment period study followed by an open label period of 1 year.